Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance
What this bill does
Requiring certain insurers, nonprofit health service plans, and health maintenance organizations to limit the cumulative amount a covered individual is required to pay on copayment or coinsurance for a covered prescription insulin drug to no more than $100, regardless of the amount or type of insulin needed to fill the covered individual's prescriptions; applying the Act to all policies, contracts, and health benefit plans issued, delivered, or renewed in the State on or after January 1, 2021; etc.
Analysis reads the bill text, the fiscal note, and the witness list. It is generated by Claude and reviewed by nobody, so check the source documents before you rely on it.